Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, ...

Strategically, Vivos achieved notable milestones including receiving FDA clearance for its devices to treat moderate to severe obstructive sleep apnea in children, and the introduction of new medical ...

Obstructive sleep apnea has been linked to an increased risk of dementia in a new study—and the association was particularly ...

Completed dosing of 115 participants in a bioavailability and bioequivalence (BA/BE) clinical trial in Australia for IHL-42X, an investigational treatment for obstructive sleep apnea in July 2024.

Bharmal said. Other health complications arising from metabolic syndrome include obstructive sleep apnea, due to the impact ...

Periodontitis is a chronic inflammatory disease that triggers a local immuno-inflammatory response ... An established ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Therapeutic strides in biotech are advancing promising candidates in clinic to address different stages of sleep apnea and ...

The World Health Organization (WHO) reports that approximately 65 million people suffer from moderate-to-severe Chronic ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Losing weight, quitting smoking, and limiting alcohol can all help ease obstructive sleep apnea symptoms such as snoring. The ...